It is sad to see commentators write about things they are clueless about – which is much like YoYo Honey Singh trying to teach M.S. Subbulakshmi how to sing Venkateshwara Subrabatham. Vaccination is one such thing where people with kindergarten knowledge are preaching the treatise! Vaccinating a billion people is a tough challenge and India with its EVin (Electronic Vaccine Intelligence Network) has the basic infrastructure in place to do it, yet we are stumbling. Not because of the absence of good intent or good policy design by the Government of India (GoI), but due to politics and its sad consequences.
First, a monopsonist, or a sole buyer, can easily aggregate demand and drive down vaccine prices. Market power in product markets exists when firms have the ability to set prices they charge, within limits of the demand curve for their products. If 30 state governments are allowed to buy, then it will lead to interstate competition and drive prices up for everyone. So, the initial policy of GoI to centrally procure vaccines and allocate it to states was the correct policy response (did someone say government’s don’t follow “evidence-based policy” design?)
Second, the supply of vaccines in India is limited and we get about 60-70 million doses a month, even though Serum Institute of India (SII) claimed they would make about 100 million doses a month by early 2021. As such the supply curve of Covid vaccines is inelastic in the short to medium term. This is the nature of the beast and cannot be improved overnight. To quote one of my intellectual role models Warren Buffet “No matter how great the talent or efforts, some things just take time. You can't produce a baby in one month by getting nine women pregnant.”
This story is from the June 13, 2021 edition of Business Today.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the June 13, 2021 edition of Business Today.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Look Before You Leap
In 2025, Investors Will Need To Factor In Volatility Across Asset Classes
"Focus on the challenge of each customer"
SHASHANK KUMAR MD & CO-FOUNDER I RAZORPAY Razorpay is India's first full-stack financial solutions company
PEDAL ON THE FUTURE
THE MG WINDSOR EV, WITH ITS FUTURISTIC AND MINIMALIST DESIGN, COMBINES THE BEST OF BOTH WORLDS-COMFORT AND TECHNOLOGY
BREATHE EASY
Whether you're battling allergies, looking to remove pollutants, or simply want to breathe easier, the right air purifier can make a difference
The Taste of India in a Glass
FROM ROYAL LIQUEURS TO DISTILLED MAHUA, INDIAN HERITAGE ALCOHOLIC BEVERAGES ARE HAVING THEIR DAY IN THE SUN
MISSING ADVISORS
INDIA HAS JUST ONE INVESTMENT ADVISOR FOR NEARLY EVERY 200,000 INVESTORS. AT A TIME WHEN RETAIL PARTICIPATION IN THE STOCK MARKETS IS BOOMING, THIS ASSUMES SIGNIFICANCE
TURNING A CORNER
SHARED ELECTRIC MOBILITY START-UP YULU'S SHIFT TO SERVICING THE QUICK COMMERCE SECTOR IS HELPING IT GROW FAST. IT IS NOW FOCUSSING ON IMPROVING ROAD SAFETY FEATURES AS IT TURNS EBITDA POSITIVE
REALITY CHECK
INDIAN STOCK MARKETS PLUNGED BEGINNING OCTOBER FOR A HOST OF REASONS, INCLUDING A FALL IN FII OWNERSHIP. HOW DEEP WILL THE CORRECTION BE?
TRUMP'S TRADE TANGO
The return of Donald Trump as the 47th President of the US has put the global economy on edge. India, too, is unlikely to remain unaffected. How will policymakers meet this latest challenge?
"The essence of the Trump administration will be transactional”
Global investor, analyst, and best-selling author Ruchir Sharma decodes why Donald Trump won the elections, what India should do, the risks, and more